In a new study from the University of Bergen (UiB), confidential drug prices have been used to evaluate coverage decisions for new drugs in Norway.
Jun 29, 2022
0
4
Unequal distribution of COVID-19 antivirals means patients are buying pills online that may not be safe when taken without medical supervision, finds an investigation published by The BMJ today.
May 31, 2022
0
26
Prescription drugs are a major source of expenditure for patients in Ireland. High prices can lead to cost-related non-adherence and adverse health outcomes. Researchers at Trinity College and RCSI University of Medicine ...
May 31, 2022
0
3
Many of the nation's most prominent hospitals are blatantly violating federal mandates requiring transparency in pricing, and all too often patients are being kept in the dark about dramatic differences between publicly reported ...
May 26, 2022
0
17
A new analysis suggests California's cap on noneconomic losses in malpractice cases has fallen far behind present-day values, and may even be associated with an increase in malpractice cases over the past five decades.
May 11, 2022
0
3
It's now two years since the World Health Organization began calling the COVID-19 outbreak a pandemic.
Mar 14, 2022
0
3
The introduction of a maximum price-cap for cigarettes sold in the UK would limit tobacco companies' ability to fix prices and would help to cut smoking rates, according to a new study from a team at the University of Bath.
Mar 3, 2022
0
34
Across the European region, alcohol consumption leads to almost one million deaths each year from a wide range of causes, including cardiovascular diseases, cancers and other noncommunicable diseases (NCDs), as well as infectious ...
Mar 1, 2022
0
1
Prices paid to anesthesia practitioners increased after hospital outpatient departments and ambulatory surgery centers contracted with a physician management company (PMC), and were substantially higher if the PMC received ...
Feb 28, 2022
0
28
French pharmaceuticals giant Sanofi said Wednesday that its COVID-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its rivals.
Feb 23, 2022
0
3
